ZVRA Insider Trading

Insider Ownership Percentage: 1.10%
Insider Buying (Last 12 Months): $112,048.33
Insider Selling (Last 12 Months): $0.00

Zevra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Zevra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zevra Therapeutics Share Price & Price History

Current Price: $5.53
Price Change: Price Increase of +0.04 (0.73%)
As of 03/31/2023 12:09 PM ET

This chart shows the closing price history over time for ZVRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Zevra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2023Tamara A SeymourDirectorBuy519$4.82$2,501.58719View SEC Filing Icon  
3/14/2023Joshua SchaferEVPBuy2,000$4.61$9,220.002,000View SEC Filing Icon  
3/10/2023R. Laduane CliftonCFOBuy1,725$4.15$7,158.7511,002View SEC Filing Icon  
3/10/2023Timothy J SangiovanniSVPBuy1,200$4.14$4,968.004,449View SEC Filing Icon  
3/9/2023Matthew R PloosterDirectorBuy11,000$4.20$46,200.0018,500View SEC Filing Icon  
3/9/2023Richard W PascoeCEOBuy10,000$4.20$42,000.0029,973View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Zevra Therapeutics (NASDAQ:ZVRA)

19.39% of Zevra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Zevra Therapeutics logo
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Read More on Zevra Therapeutics

Today's Range

Now: $5.53
Low: $5.36
High: $5.64

50 Day Range


52 Week Range

Now: $5.53
Low: $4.00
High: $6.92


54,100 shs

Average Volume

228,851 shs

Market Capitalization

$191.01 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Zevra Therapeutics?

Zevra Therapeutics' top insider investors include:
  1. Richard W Pascoe (CEO)
  2. Matthew R Plooster (Director)
  3. R Laduane Clifton (CFO)
  4. Timothy J Sangiovanni (SVP)
  5. Joshua Schafer (EVP)
  6. Tamara A Seymour (Director)
Learn More about top insider investors at Zevra Therapeutics.